Skip to main content

Detection of circulating E/S antigens in the sera of patients with fascioliasis by IELISA: a tool of serodiagnosis and assessment of cure

Buy Article:

$43.00 plus tax (Refund Policy)


An IELISA was developed to evaluate the performance of Fasciola E/S antigens in diagnosis and cure assessment of human Fasciola infection. Twenty patients with acute (prepatent) fascioliasis and another 20 with patent infection were enrolled in the study. Patients were treated with TCZ and followed at 1, 3 and 6 months after therapy. At inspection, the sensitivity of the test to diagnose prepatent cases was 100% compared to 70% for patent infections. There was a gradual decrease of antigenaemia over the follow-up period in acute cases. In chronic cases antigen disappeared from 13 cases (65%) at 1 month; this proportion did not change at 3 or 6 months.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: E/S antigens; Human fascioliasis; IELISA

Document Type: Research Article

Affiliations: 1: Department of Parasitology, Medical Research Institute, University of Alexandria, Egypt 2: Department of Immunology, Medical Research Institute, University of Alexandria, Egypt 3: Department of Tropical Health, High Institute of Public Health, University of Alexandria, Egypt 4: Department of Biochemistry, Medical Research Institute, University of Alexandria, Egypt

Publication date: 1999-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more